Parallel Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Parallel Advisors’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,867	Closed	-$1.1K	–	3455
2024 Q1	$1.1K	Hold	7,867	–	–	﹤0.01%	2920
2023 Q4	$1.14K	Hold	7,867	–	–	﹤0.01%	2912
2023 Q3	$1.38K	Hold	7,867	–	–	﹤0.01%	2909
2023 Q2	$24.5K	Buy	+7,867	New	+$23.4K	﹤0.01%	1752

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Parallel Advisors's GRTX Position: Q2 2024 in Review

Parallel Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 7,867 shares — an estimated $1.1K sold.

Parallel Advisors first reported a position in GRTX in Q2 2023 and held it in 4 quarters. The position peaked at $24.5K in Q2 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Parallel Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Parallel Advisors sold 7,867 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1.1K.
Parallel Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Parallel Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $24.5K in Q2 2023.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.